Effect of bacteriophages on cutaneous inflammation in acne

噬菌体对痤疮皮肤炎症的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): This proposal describes a 5-year training program for the development of an academic career in Dermatology, with a focus on furthering our understanding of how the cutaneous microbiome influences the immunobiology of the skin, using acne as a model. As principal investigator of this project, I am currently a postdoctoral researcher with training in microbiology, molecular biology, dermatology and immunology, all fields of study encompassed by this proposal, which is aimed at elucidating how Propionibacterium acnes bacteriophages can modulate the way in which this bacterium interacts with human cells in skin to trigger innate immune responses. My mentor on this project, who will oversee my career development, is Dr. Robert L. Modlin, a world-renowned immunologist and dermatologist at UCLA. Ongoing studies in his laboratory involve deciphering the mechanisms of host defense and innate immunity in skin, both of which are relevant to this proposal. Dr. Jenny Kim, who is also a dermatologist and professor at UCLA and a leading researcher in the study of the immunological basis of acne, will serve as my co-mentor. In the short-term, my objective is to elucidate how cutaneous bacteriophages can modulate the innate response to P. acnes in the context of both acne and healthy skin. My long-term career goal is to be an independent investigator in academic dermatology, and using the skin disease acne as a model, to develop a research program aimed at uncovering the mechanisms by which microorganisms interact with their hosts to trigger immune responses in the skin. Ultimately I hope to apply the insights gained from this research to develop improved therapeutics for the treatment of skin disease. This research proposal is based upon the hypothesis that the bacteriophage lysis, which involves degradation of cell wall components and the release of bacterial ligands, modulates the cutaneous innate immune response to P. acnes. In order to test this hypothesis I am proposing three specific aims. These include: 1) Elucidate innate pathways modulated by stimulation of monocytes with phage-killed P. acnes; 2) Investigate the mechanism through which bacteriophages alter P. acnes-induced immune responses according to specific effects on pattern recognition receptor activation pathways; and 3) Investigate how bacteriophage infection influences host immune responses at the site of disease. It is anticipated that the proposed studies will provide novel insights into the immunobiology of the skin, as through this work, we will define the mechanisms by which cutaneous bacteriophages can modulate innate responses, leading to the induction of distinct cytokine responses and functional outcomes that can influence acne pathogenesis. The investigation of the mechanisms by which bacteriophage lysis of a bacterial host modulates the cutaneous innate immune response is a novel area of exploration, and the studies outlined in this proposal have the potential to generate new insights into the role of bacteriophages in acne, the understanding of which will be critical for the ultimate goal of developing safe and effective phage-based acne therapies.
描述(由申请人提供):该提案描述了一个为期 5 年的皮肤病学学术职业发展培训计划,重点是以痤疮为模型,进一步了解皮肤微生物组如何影响皮肤的免疫生物学。作为该项目的主要研究者,我目前是一名博士后研究员,接受过微生物学、分子生物学、皮肤病学和免疫学方面的培训,该提案涵盖了所有研究领域,其目的是阐明痤疮丙酸杆菌噬菌体如何调节这种细菌与皮肤中的人体细胞相互作用的方式,以触发先天免疫反应。我在这个项目上的导师是加州大学洛杉矶分校 (UCLA) 世界著名的免疫学家和皮肤科医生 Robert L. Modlin 博士,他将监督我的职业发展。他的实验室正在进行的研究涉及破译皮肤的宿主防御和先天免疫机制,这两者都与该提议相关。 Jenny Kim 博士是加州大学洛杉矶分校的皮肤科医生和教授,也是痤疮免疫学基础研究的领先研究员,她将担任我的共同导师。在短期内,我的目标是阐明皮肤噬菌体如何在痤疮和健康皮肤的背景下调节对痤疮丙酸杆菌的先天反应。我的长期职业目标是成为学术皮肤病学的独立研究者,并以痤疮皮肤病为模型,开发一项研究计划,旨在揭示微生物与其宿主相互作用以触发皮肤免疫反应的机制。最终,我希望应用从这项研究中获得的见解来开发治疗皮肤病的改进疗法。该研究提案基于这样的假设:噬菌体裂解涉及细胞壁成分的降解和细菌配体的释放,调节皮肤对痤疮丙酸杆菌的先天免疫反应。为了检验这个假设,我提出了三个具体目标。这些包括: 1) 阐明用噬菌体杀死的痤疮丙酸杆菌刺激单核细胞所调节的先天途径; 2)研究噬菌体根据对模式识别受体激活途径的特定影响改变痤疮丙酸杆菌诱导的免疫反应的机制; 3) 研究噬菌体感染如何影响疾病部位的宿主免疫反应。预计拟议的研究将为皮肤免疫生物学提供新的见解,因为通过这项工作,我们将定义皮肤噬菌体调节先天反应的机制,从而诱导不同的细胞因子反应和影响痤疮发病机制的功能结果。对细菌宿主的噬菌体裂解调节皮肤先天免疫反应的机制的研究是一个新的探索领域,本提案中概述的研究有可能对噬菌体在痤疮中的作用产生新的见解,对此的理解对于开发安全有效的基于噬菌体的痤疮疗法的最终目标至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura Jane Marinelli其他文献

Laura Jane Marinelli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura Jane Marinelli', 18)}}的其他基金

Effect of bacteriophages on cutaneous inflammation in acne
噬菌体对痤疮皮肤炎症的影响
  • 批准号:
    8750803
  • 财政年份:
    2014
  • 资助金额:
    $ 13.26万
  • 项目类别:
Effect of bacteriophages on cutaneous inflammation in acne
噬菌体对痤疮皮肤炎症的影响
  • 批准号:
    8899445
  • 财政年份:
    2014
  • 资助金额:
    $ 13.26万
  • 项目类别:
Effect of bacteriophages on cutaneous inflammation in acne
噬菌体对痤疮皮肤炎症的影响
  • 批准号:
    9116713
  • 财政年份:
    2014
  • 资助金额:
    $ 13.26万
  • 项目类别:
Characterization of the Lysogenic Pathway in P. acnes Bacteriophages
痤疮丙酸杆菌噬菌体溶原途径的表征
  • 批准号:
    8334125
  • 财政年份:
    2011
  • 资助金额:
    $ 13.26万
  • 项目类别:
Characterization of the Lysogenic Pathway in P. acnes Bacteriophages
痤疮丙酸杆菌噬菌体溶原途径的表征
  • 批准号:
    8526192
  • 财政年份:
    2011
  • 资助金额:
    $ 13.26万
  • 项目类别:
Characterization of the Lysogenic Pathway in P. acnes Bacteriophages
痤疮丙酸杆菌噬菌体溶原途径的表征
  • 批准号:
    8056677
  • 财政年份:
    2011
  • 资助金额:
    $ 13.26万
  • 项目类别:

相似海外基金

Metagenomic discovery and optimization of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
针对痤疮皮肤杆菌治疗寻常痤疮的新型内溶素的宏基因组发现和优化
  • 批准号:
    10821291
  • 财政年份:
    2023
  • 资助金额:
    $ 13.26万
  • 项目类别:
Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.
用于口服治疗顽固性结节性痤疮的选择性 CYP26 抑制剂。
  • 批准号:
    10822482
  • 财政年份:
    2023
  • 资助金额:
    $ 13.26万
  • 项目类别:
ENLIGHT : Light-sensitive Engineered Living Material for acne therapy
ENLIGHT:用于痤疮治疗的光敏工程活性材料
  • 批准号:
    EP/Y03029X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 13.26万
  • 项目类别:
    Fellowship
Developing a novel medical-grade microneedle patch to treat acne vulgaris
开发一种新型医用级微针贴片来治疗寻常痤疮
  • 批准号:
    10053162
  • 财政年份:
    2023
  • 资助金额:
    $ 13.26万
  • 项目类别:
    Collaborative R&D
Smart Photodynamic Therapy for Acne by Reversibly Switchable Intersystem Crossing in Pure Organic Materials
通过纯有机材料中的可逆可切换系间交叉来治疗痤疮的智能光动力疗法
  • 批准号:
    10483461
  • 财政年份:
    2022
  • 资助金额:
    $ 13.26万
  • 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
  • 批准号:
    10502200
  • 财政年份:
    2022
  • 资助金额:
    $ 13.26万
  • 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
  • 批准号:
    10698121
  • 财政年份:
    2022
  • 资助金额:
    $ 13.26万
  • 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
  • 批准号:
    10404440
  • 财政年份:
    2022
  • 资助金额:
    $ 13.26万
  • 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
  • 批准号:
    10404436
  • 财政年份:
    2022
  • 资助金额:
    $ 13.26万
  • 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
  • 批准号:
    10296086
  • 财政年份:
    2021
  • 资助金额:
    $ 13.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了